Related Experiment Video
Updated: May 5, 2026
05:12
Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
3.1K
Radiofrequency-triggered pacemakers: uses and limitations. A long-term study
Annals of Internal Medicine
|January 1, 1978
Summary
Radiofrequency pacemakers effectively controlled arrhythmias in most patients with recurrent supraventricular or ventricular tachycardia. Careful patient selection is crucial for optimal outcomes with these devices.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Recurrent supraventricular tachycardia (SVT), alternating bradycardia-tachycardia, and ventricular tachycardia (VT) pose significant management challenges.
- Standard drug therapies may be insufficient for refractory arrhythmias, necessitating advanced interventions.
Observation:
- Seven patients with refractory arrhythmias (five SVT, one alternating bradycardia-tachycardia, one VT) received permanent radiofrequency-triggered pacemakers.
- Follow-up averaged 36 months, assessing pacemaker efficacy and long-term outcomes.
Findings:
- Arrhythmia control was achieved in five of seven patients, with three requiring adjunctive medication.
- Overdrive pacing proved ineffective for one patient with Wolff-Parkinson-White syndrome and recurrent atrial arrhythmias.
- One patient with VT became refractory to overdrive atrial pacing.
Implications:
- Radiofrequency pacemakers demonstrate long-term effectiveness in select patients with recurrent, drug-refractory cardiac arrhythmias.
- Pre-implantation electrophysiologic studies and careful patient selection are mandatory for successful radiofrequency pacemaker implantation.
- Understanding the benefits and limitations of radiofrequency pacemakers is essential for guiding treatment decisions between pacing and surgical interventions.
